Cardiac Organoids in Niches Technology Development Program

Our mission is to transform cardiovascular research and drug discovery by developing a scalable, human-centric, and regulatory-ready NAMs platform that integrates biology, engineering, and data science to bridge fundamental discovery with clinical translation.

We envision a future where human-based models replace animal testing, enabling safer, faster, and more precise development of cardiovascular therapies, while establishing new standards for predictive and translational biomedical research.

• Establish COIN as a gold-standard NAMs platform for cardiovascular research
• Advance cardiac safety pharmacology and drug discovery through human-centric models
• Enable patient-specific and population-level disease modeling
• Align with FDA, OECD, and EPA regulatory frameworks to support NAMs adoption
• Promote open science, FAIR data sharing, and reproducibility
• Train the next generation of interdisciplinary scientists in NAMs, AI, biomaterials, and translational research

Watch the official trailer

Watch the related video